HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.

Abstract
The goal of this study was to determine if the multiple marker screening test (maternal serum alpha-fetoprotein, unconjugated estriol, human chorionic gonadotrophin, and maternal age) detects fetal Turner syndrome or just cystic hygroma/hydrops. Multiple marker screening tests from 4 groups were compared: 1) Turner syndrome with hydrops/ hygroma group (n = 10) = fetuses with cystic hygroma/hydrops and a 45X karyotype, 2) Turner syndrome without hydrops/hygroma (n = 9) = sonographically unremarkable fetal Turner syndrome or Turner mosaic, 3) hydrops group (n = 8) = all cases of fetal cystic hygroma/hydrops excluding Turner syndrome, 4) sex chromosome aneuploidy group (n = 16) = other sonographically normal fetal sex chromosome aneuploidies. Positive screening tests (Down syndrome risk > or = 1:190 or MSAFP > or = 2.5 MOM) were found in 60% (6/10) of the Turner syndrome with hydrops/hygroma group, but only 11% (1/9) of the Turner syndrome without hydrops/hygroma group (P = .04). The incidence of positive screening tests in the Hydrops group was 75% (6/8), while it was only 12.5% (2/16) in the other sex chromosome aneuploidy group. We conclude that the multiple marker screening test identifies fetuses with cystic hygroma/hydrops, and may do so independently of the etiology of the hydrops.
AuthorsK D Wenstrom, L R Boots, P C Cosper
JournalThe Journal of maternal-fetal medicine (J Matern Fetal Med) 1996 Jan-Feb Vol. 5 Issue 1 Pg. 31-5 ISSN: 1057-0802 [Print] United States
PMID8796763 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Chorionic Gonadotropin
  • alpha-Fetoproteins
  • Estriol
Topics
  • Adolescent
  • Adult
  • Aneuploidy
  • Biomarkers (blood)
  • Chorionic Gonadotropin (blood)
  • Down Syndrome (diagnosis, epidemiology, genetics)
  • Estriol (blood)
  • Female
  • Fetal Diseases (diagnosis, epidemiology, genetics)
  • Genetic Testing (methods)
  • Humans
  • Hydrops Fetalis (diagnosis, epidemiology, genetics)
  • Incidence
  • Karyotyping
  • Lymphangioma, Cystic (diagnosis, epidemiology, genetics)
  • Maternal Age
  • Pregnancy
  • Prenatal Diagnosis (methods)
  • Sex Chromosomes
  • Turner Syndrome (diagnosis, epidemiology, genetics)
  • alpha-Fetoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: